{"anticipatedPostingDate":"2009-11","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"15"}],"units":"Participants"}],"description":"Number of patients who were alive and free of disease (malignancy) at 6 months after transplant.","groups":[{"description":"All patients receiving full study treatment with chemotherapy and radiation, along with natural killer cells, aldesleukin and umbilical cord blood transplant.","id":"OG000","title":"Evaluable Patients"}],"paramType":"NUMBER","populationDescription":"One patient did not receive umbilical cord transplant and was not included in this Evaluable patient group.","reportingStatus":"POSTED","timeFrame":"6 Months Post Transplant","title":"Number of Participants (Patients) Who Were Disease-free and Alive at 6 Months","type":"PRIMARY","unitOfMeasure":"Participants"}